| 000 | 01785 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250513112443.0 | ||
| 264 | 0 | _c19970528 | |
| 008 | 199705s 0 0 eng d | ||
| 022 | _a1067-5582 | ||
| 024 | 7 |
_a10.1097/00002371-199611000-00008 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVlock, D R | |
| 245 | 0 | 0 |
_aPhase II trial of interferon-alpha in locally recurrent or metastatic squamous cell carcinoma of the head and neck: immunological and clinical correlates. _h[electronic resource] |
| 260 |
_bJournal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy _cNov 1996 |
||
| 300 |
_a433-42 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aCarcinoma, Squamous Cell _ximmunology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHead and Neck Neoplasms _ximmunology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterferon-alpha _xadverse effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplasm Recurrence, Local _ximmunology |
| 650 | 0 | 4 | _aSurvival Analysis |
| 700 | 1 | _aAndersen, J | |
| 700 | 1 | _aKalish, L A | |
| 700 | 1 | _aJohnson, J T | |
| 700 | 1 | _aKirkwood, J M | |
| 700 | 1 | _aWhiteside, T | |
| 700 | 1 | _aHerberman, R B | |
| 700 | 1 | _aAdams, G S | |
| 700 | 1 | _aOken, M M | |
| 700 | 1 | _aHaselow, R E | |
| 773 | 0 |
_tJournal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy _gvol. 19 _gno. 6 _gp. 433-42 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00002371-199611000-00008 _zAvailable from publisher's website |
| 999 |
_c9030073 _d9030073 |
||